These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 29673412)

  • 1. Methods for the economic evaluation of changes to the organisation and delivery of health services: principal challenges and recommendations.
    Meacock R
    Health Econ Policy Law; 2019 Jan; 14(1):119-134. PubMed ID: 29673412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opportunity costs and local health service spending decisions: a qualitative study from Wales.
    Karlsberg Schaffer S; Sussex J; Hughes D; Devlin N
    BMC Health Serv Res; 2016 Mar; 16():103. PubMed ID: 27012523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generalisability in economic evaluation studies in healthcare: a review and case studies.
    Sculpher MJ; Pang FS; Manca A; Drummond MF; Golder S; Urdahl H; Davies LM; Eastwood A
    Health Technol Assess; 2004 Dec; 8(49):iii-iv, 1-192. PubMed ID: 15544708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes measurement: health state preferences and economic evaluation.
    Oldridge NB
    Assist Technol; 1996; 8(2):94-102. PubMed ID: 10163933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic evaluation and health care decision-making.
    Rutten F
    Health Policy; 1996 Jun; 36(3):215-29. PubMed ID: 10158267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of economic evaluation in mental health care.
    Singh B; Hawthorne G; Vos T
    Aust N Z J Psychiatry; 2001 Feb; 35(1):104-17. PubMed ID: 11270444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Health technology assessment: II. Cost effectiveness analysis].
    Secoli SR; Nita ME; Ono-Nita SK; Nobre M
    Arq Gastroenterol; 2010; 47(4):329-33. PubMed ID: 21225140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The political economy of the assessment of value of new health technologies.
    Karnon J; Edney L; Afzali H
    J Health Serv Res Policy; 2018 Apr; 23(2):116-122. PubMed ID: 29320891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The U.K. NHS economic evaluation database. Economic issues in evaluations of health technology.
    Nixon J; Stoykova B; Glanville J; Christie J; Drummond M; Kleijnen J
    Int J Technol Assess Health Care; 2000; 16(3):731-42. PubMed ID: 11028129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost collection and analysis for health economic evaluation.
    Smith KA; Rudmik L
    Otolaryngol Head Neck Surg; 2013 Aug; 149(2):192-9. PubMed ID: 23641023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How has the impact of 'care pathway technologies' on service integration in stroke care been measured and what is the strength of the evidence to support their effectiveness in this respect?
    Allen D; Rixson L
    Int J Evid Based Healthc; 2008 Mar; 6(1):78-110. PubMed ID: 21631815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of costs for health economic evaluation.
    Riewpaiboon A
    J Med Assoc Thai; 2014 May; 97 Suppl 5():S17-26. PubMed ID: 24964695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimating costs in the economic evaluation of medical technologies.
    Luce BR; Elixhauser A
    Int J Technol Assess Health Care; 1990; 6(1):57-75. PubMed ID: 2113891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is there an alternative to quality-adjusted life years for supporting healthcare decision making?
    Beresniak A; Dupont D
    Expert Rev Pharmacoecon Outcomes Res; 2016 Jun; 16(3):351-7. PubMed ID: 27139424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Revolution then evolution: the advance of health economic evaluation in Australia.
    Lopert R; Viney R
    Z Evid Fortbild Qual Gesundhwes; 2014; 108(7):360-6. PubMed ID: 25444293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Health Economics Approach to US Value Assessment Frameworks-Summary and Recommendations of the ISPOR Special Task Force Report [7].
    Garrison LP; Neumann PJ; Willke RJ; Basu A; Danzon PM; Doshi JA; Drummond MF; Lakdawalla DN; Pauly MV; Phelps CE; Ramsey SD; Towse A; Weinstein MC
    Value Health; 2018 Feb; 21(2):161-165. PubMed ID: 29477394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The complex interface between economy and healthcare: An introductory overview for clinicians.
    Ottolini FL; Buggio L; Somigliana E; Vercellini P
    Eur J Intern Med; 2016 Dec; 36():1-6. PubMed ID: 27577606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness analysis of humanitarian relief interventions: visceral leishmaniasis treatment in the Sudan.
    Griekspoor A; Sondorp E; Vos T
    Health Policy Plan; 1999 Mar; 14(1):70-6. PubMed ID: 10351471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Funding fertility: issues in the allocation and distribution of resources to assisted reproduction technologies.
    Devlin N; Parkin D
    Hum Fertil (Camb); 2003 May; 6 Suppl 1():S2-6. PubMed ID: 12869768
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.